Calendar Navidea Biopharmaceuticals, Inc.

Equities

Market Closed - OTC Markets Other stock markets 10:38:31 26/04/2024 pm IST			5-day change	1st Jan Change
0.0381 ^USD	+1.33%		+8.86%	-30.98%

2023	Navidea Biopharmaceuticals, Inc. announced that it expects to receive $0.75 million in funding	CI
2023	Navidea Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

b2a4e9421.iHg4wYYOLqiiozzVM-ejcEWaenfI1thDDMF5sF8r6VU.-xlrgvZFfebPk1ezddLyRB_CQiaHlboFPrQT4xFFpD3FNwql3HZx3_XybQ~616c0c299f57c7950a7771634ea67ff2

07/05/2024	Q1 2024 Earnings Release (Projected)
07/08/2024	Q2 2024 Earnings Release (Projected)
06/11/2024	Q3 2024 Earnings Release (Projected)

16/11/2023 11:30 pm	Annual General Meeting
14/11/2023	Q3 2023 Earnings Release
27/07/2023 10:30 pm	Extraordinary Shareholders Meeting
08/06/2023 01:30 am	Q1 2023 Earnings Release
22/03/2023 02:30 am	Q4 2022 Earnings Call
22/03/2023 01:31 am	Q4 2022 Earnings Release
08/12/2022 11:30 pm	Annual General Meeting
16/11/2022 03:30 am	Q3 2022 Earnings Call
14/11/2022 06:30 pm	Q3 2022 Earnings Release
10/11/2022 07:30 pm	Annual Meeting of the Society for Immunotherapy of Cancer - Abstract #1161
10/11/2022	American College of Rheumatology Convergence Conference
09/09/2022 01:30 am	Interim 2022 Earnings Call
15/08/2022 06:00 pm	Interim 2022 Earnings Release
12/06/2022 06:30 am	Society of Nuclear Medicine and Molecular Imaging Meeting - Abstract No-197
13/05/2022 02:30 am	Q1 2022 Earnings Call
12/05/2022 05:00 pm	Q1 2022 Earnings Release
21/04/2022 02:30 am	NAV3-32 Phase 2B Study Results Call
15/04/2022 02:30 am	Business Update Call
24/03/2022 02:30 am	FY 2021 Earnings Call
23/03/2022 05:00 pm	FY 2021 Earnings Release

Fiscal Period	December	2018	2019	2020
Net sales Million USD	Released Forecast Spread	1,17	0,66 0,77 -14.18%	0,92 0,90 2.18%
EBITDA	Released Forecast Spread	0,00	0,00 0,00 -	0,00 0,00 -
EBIT Million USD	Released Forecast Spread	0,00	-11,0 -11,0 0.09%	-10,7 -12,1 11.2%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	0,00	-10,9 -11,0 0.17%	-10,7 -12,1 11.02%
Net income Million USD	Released Forecast Spread	0,00	-10,9 -11,0 0.16%	-11,4 -12,1 5.51%
EPS USD	Released Forecast Spread	-1,80	-0,76 -0,74 -3.4%	-0,48 -0,48 0%
Announcement Date		-	11/03/20	24/03/21

Fiscal Period	December	2021 Q3
Net sales Million USD	Released Forecast Spread	0,10 0,00 -
EBIT Million USD	Released Forecast Spread	-2,42 -3,52 31.26%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-2,42 -3,52 31.26%
Net income Million USD	Released Forecast Spread	-2,44 -3,52 30.8%
EPS USD	Released Forecast Spread	-0,08 -0,11 27.27%
Announcement Date		10/11/21

29/04/2024	BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
29/04/2024	SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
29/04/2024	JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
29/04/2024	MORPHOSYS AG: Q1 2024 Earnings Release
30/04/2024 01:35 am	QIAGEN N.V.: Q1 2024 Earnings Release
30/04/2024	CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
01/05/2024	DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024	PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024	EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024	AZENTA, INC.: Q2 2024 Earnings Release (Projected)

Today	GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
Today	GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 10:30 am	BB BIOTECH AG: Q1 2024 Earnings Release
26/04/2024	BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024	PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
26/04/2024	HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
26/04/2024	BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
26/04/2024	CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 04:30 pm	MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
25/04/2024 11:30 am	PURETECH HEALTH PLC: Q4 2023 Earnings Release